Oral administration of γ-glutamylcysteine increases intracellular glutathione levels above homeostasis in a randomised human trial pilot study

Autor: Martin Hani Zarka, Wallace Bridge
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
NADP
nicotinamide adenine dinucleotide phosphate

GSH
reduced glutathione

Clinical Biochemistry
Intracellular glutathione
Administration
Oral

NAC
N-acetylcysteine

Pilot Projects
Pharmacology
medicine.disease_cause
Biochemistry
chemistry.chemical_compound
0302 clinical medicine
Oral administration
C0
initial basal concentration (GSH)

Homeostasis
GR
glutathione reductase

Lymphocytes
GCLC
catalytic subunit of glutamate cysteine ligase

γ-GT
gamma-glutamyltransferase

lcsh:QH301-705.5
lcsh:R5-920
FACS
Fluorescence activated cell sorting

GCLM
Dipeptides
Middle Aged
Glutathione
Healthy Volunteers
Clinical trial
GCLC
Female
lcsh:Medicine (General)
Research Paper
Adult
GCLM
modifier subunit of glutamate cysteine ligase

Glutamate-Cysteine Ligase
PBMC
peripheral blood mononuclear cell x̄ - mean

s
standard deviation

tmax
time to reach Cmax

Cmax
maximum concentration (GSH)

Biology
Glutamylcysteine
Peripheral blood mononuclear cell
03 medical and health sciences
medicine
Humans
AUC
Area under the curve. Overall exposure (to GSH change)

Organic Chemistry
γ-GC
gamma-glutamylcysteine

GCL
glutamate cysteine ligase holoenzyme

030104 developmental biology
chemistry
lcsh:Biology (General)
GS
glutathione synthetase

Immunology
030217 neurology & neurosurgery
Oxidative stress
Zdroj: Redox Biology, Vol 11, Iss, Pp 631-636 (2017)
Redox Biology
ISSN: 2213-2317
Popis: Objective To determine if orally dosed γ-glutamylcysteine (γ-GC) can increase cellular glutathione (GSH) levels above homeostasis. Many chronic and age-related disorders are associated with down-regulation, or impairment, of glutamate cysteine ligase (GCL). This suggests that γ-GC supply may become limiting for the maintenance of cellular GSH at the normal levels required to effectively protect against oxidative stress and any resulting physiological damage. Methods GSH levels were measured in lymphocytes of healthy, non-fasting participants before and after single oral doses (2 and 4 g) of γ-GC. Blood samples were immediately processed using high speed fluorescence-activated cell sorting to isolate 106 lymphocytes that were then assayed for GSH content. Results A single 2 g dose of γ-GC increased lymphocyte GSH content above basal levels (53±47%, p
Graphical abstract fx1
Databáze: OpenAIRE